News | August 20, 2014

Boston Scientific, Asahi Intecc Announce Joint Development, Manufacturing Programs

August 20, 2014 — Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. The joint project focuses on creating a device intended to improve handling compared to existing FFR wires.

The FFR market is an emerging field in interventional cardiology that exceeds $250 million worldwide and is experiencing a double-digit growth rate. FFR-guided percutaneous coronary intervention (PCI) is cost-effective and also reduces one-year major adverse cardiac events (MACE) rates. The jointly developed FFR wire will be designed for use with the Boston Scientific Polaris multimodality imaging system.

The companies have also agreed to collaborate on key enhancements to the Boston Scientific RotaWire atherectomy guidewire. Asahi Intecc will provide components for the new RotaWire, which is designed by Boston Scientific to provide improved control and handling. The RotaWire is a unique 0.009-inch wire that is used within the Rotablator rotational atherectomy system to treat calcified lesions in coronary arteries.

The introduction of the components manufactured by Asahi Intecc to advance the RotaWire atherectomy guidewire is further evidence of the Boston Scientific commitment to improving products used in the treatment of complex coronary disease.

"We expect our collaboration with Asahi Intecc to help improve care for patients with coronary artery disease and strengthen our interventional cardiology portfolio," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. "The Asahi Intecc expertise in guidewire technology is unparalleled. By leveraging the strengths of our technologies, we have the opportunity to create truly differentiated products."

"Boston Scientific has advanced sensor and atherectomy technologies. By combining these technologies with our expertise in wires and components, we believe the manipulability of these products will improve dramatically," said Masahiko Miyata, president and CEO, Asahi Intecc. "Through our collaboration with Boston Scientific, we are confident that we will be able to help improve outcomes for patients."

Asahi Intecc specializes in wire drawing, wire forming, torque transmission and coating processes for percutaneous transluminal coronary angiography (PTCA) guidewires.

Boston Scientific anticipates commercializing both specialty wires in 2015.

For more information: www.bostonscientific.com

Related Content

Videos | Angiography| November 22, 2017
Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (
Videos | Radial Access| November 22, 2017
Mladen I.
Avinger Receives 510(k) Clearance for Pantheris Image-Guided Atherectomy Device Modifications
Technology | Atherectomy Devices| November 20, 2017
November 20, 2017 — Avinger Inc. announced in October that the company received 510(k) clearance from the U.S.
Videos | 3-D Printing| November 17, 2017
Dee Dee Wang, M.D., Director, Structural Heart Imaging at Henry Ford Hospital, Detroit, explains how her center uses
Videos | Stents Bifurcation| November 15, 2017
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morris
Videos | TCT| November 15, 2017
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiova
Videos | FFR Technologies| November 15, 2017
A discussion with William Fearon, M.D.
Philips Azurion Image-Guided Therapy Platform Improves Clinical Workflow for Interventional Procedures
News | Angiography| November 15, 2017
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow...
Videos | Heart Valve Technology| November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
Videos | Left Atrial Appendage (LAA) Occluders| November 14, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
Overlay Init